LHX3 is an advanced-stage prognostic biomarker and metastatic oncogene in hepatocellular carcinoma
{{output}}
Background: Hepatocellular carcinoma (HCC) is a common cancer and exhibits high morbidity and mortality in the world. We recently identified LHX3 as a preferentially expressed gene with a possible involvement in HCC. ... ...
